CL

Colgate-Palmolive Company
D

CL

Arincen76/100B

If you had invested in Colgate-Palmolive Company ago, it would be worth $1,839 today, against $4,096 in SPY and $6,368 in QQQ.

ArincenArincen ScoreBeta

76/100

Six parts of the company, five checks each, from its own reported figures. A part scores the checks it passes out of 10; the score is their average out of 100.

Profitability8

Plus shows the checks behind each part of the score, what passed, what failed and the figure it read, for every stock.

Cash10

Plus shows the checks behind each part of the score, what passed, what failed and the figure it read, for every stock.

Valuation7.5

Plus shows the checks behind each part of the score, what passed, what failed and the figure it read, for every stock.

Growth6

Plus shows the checks behind each part of the score, what passed, what failed and the figure it read, for every stock.

Financial strength8

Plus shows the checks behind each part of the score, what passed, what failed and the figure it read, for every stock.

Shareholders6

Plus shows the checks behind each part of the score, what passed, what failed and the figure it read, for every stock.

Figures to FY2025; the price as of today.

Colgate-Palmolive Company key facts

Style
Dividend stock · 6.2/10Growth 3.1 · Value 3.6 · Dividend 6.2
Day range
98.100 – 99.010
52-week range
75.960 – 101.180
Market capitalization
78.50B USD
P/E
38.36
PEG ratio
2.48
EPS
2.57
Div Yield
2.15%
EPS growth forecast (FY2026)
+6.1%
Volume
30,866
Beta
0.31
ESG score
68.6/100Environment 69 · Social 69 · Governance 68
Sector
Consumer Defensive
Industry
Household & Personal Products
CEO
Noel R. Wallace
Employees
34K
IPO date
2 May 1973

Colgate-Palmolive Company earnings

Next earnings · Q4 FY2026
EPS estimate
0.98 USD
Revenue estimate
5.36B USD
Last quarter · Q3 FY2026
EPS0.97Beat +4.8%Revenue5.37BBeat +0.6%

Revenue

ReportedEstimate

EPS

ReportedEstimate
PeriodReport dateEPS estimateReported EPSSurpriseEPS growthRevenue estimateReported revenueSurpriseRevenue growth
Q3 FY20271.02——+5.40%5.48B——+2.16%
Q2 FY20271.02——+3.00%5.48B——+2.21%
Q1 FY20270.97——+0.40%5.44B——+2.13%
Q4 FY20260.98——+3.16%5.36B——+2.53%
Q3 FY20260.930.97+4.75%+6.59%5.34B5.37B+0.61%+4.64%
Q2 FY20260.950.99+4.54%+7.61%5.36B5.36B+0.06%+4.91%
Q1 FY20260.940.97+2.86%+6.59%5.22B5.32B+2.07%+8.41%
Q4 FY20250.910.95+4.17%+4.40%5.12B5.23B+2.09%+5.76%
Q3 FY20250.890.91+2.36%0.00%5.13B5.13B+0.08%+1.95%
Q2 FY20250.900.92+2.56%+1.10%5.04B5.11B+1.48%+1.03%

Analysts' estimates for FY2026 over the last 7 days:EPS Revenue How the estimates moved

Colgate-Palmolive Company analyst forecast

12-month price target
101.00 USD
+2.28%

Analysts' 1-year price targets range from 95.00 to 112.00, with an average of 101.00.

Past year
1-year forecast
Strong sellStrong buy
Buy
17 ratings
Buy
12
Hold
5
Sell
0

12-month price target

Highest target112.00
Average target101.00
Lowest target95.00
Current price98.75

Colgate-Palmolive Company valuation

Price to earnings ratio (TTM)
38.36
Forward P/E (FY2026)
25.22
Price to sales (TTM)
3.69
Price to book
272.56
EV / EBITDA (TTM)
21.93

Capital structure

Market capitalization
78.50B USD
+
Total debt
7.72B USD
−
Cash and short-term investments
1.53B USD
=
Enterprise value
84.69B USD

Valuation over time

P/EForward P/EForward P/E · EstimateEstimate
Fiscal yearP/EForward P/EP/SP/BEV/EBITDA
FY2028 (est.)22.39————
FY2027 (est.)24.0722.39———
FY2026 (est.)25.2224.07———
Now (TTM)38.3624.223.69272.5621.93
FY202529.9320.183.141,183.4014.62
FY202425.7522.333.70350.6516.85
FY202328.6722.333.39108.3017.44
FY202236.9924.743.67164.3422.06
FY202133.3422.544.14118.4121.04

Colgate-Palmolive Company against its own history

Each figure in the latest fiscal year against the same figure from FY2021 to FY2025: the range, its median (the line) and the latest (the dot, green on the good side of the median). The P/E is today's against its daily readings of five years.

Its peers: The Estée Lauder Companies, Kimberly-Clark, Church & Dwight Co., The Procter & Gamble, and The Clorox, the US Household & Personal Products companies closest to it in size, each in its own latest fiscal year: their median (the line) and its rank among them, first being the best.

  • P/E (today)Above its median38.4
    20.942.9
  • Gross marginAbove its median60.1%
    56.5%60.2%
    Against its peers: 2 of 6Peers' median 44.7%
  • Operating marginLowest in 5 years16.2%
    16.2%22.3%
    Against its peers: 4 of 6Peers' median 17.4%
  • Net marginBelow its median10.5%
    9.9%14.4%
    Against its peers: 4 of 6Peers' median 11.7%
  • Return on equityHighest in 5 years3,948.1%
    355.7%3,948.1%
    Against its peers: 1 of 6Peers' median 29.5%
  • Free cash flow marginHighest in 5 years17.8%
    10.4%17.8%
    Against its peers: 1 of 6Peers' median 9.5%
  • Revenue growthLowest in 5 years1.4%
    1.4%8.3%
    Against its peers: 4 of 6Peers' median 1.6%
  • EPS growthLowest in 5 years-25.1%
    -25.1%30.0%
    Against its peers: 4 of 5Peers' median -9.0%
  • Debt to EBITDABelow its median1.76×
    1.75×2.75×
    Against its peers: 3 of 6Peers' median 2.21×
  • Current ratioLowest in 5 years0.83
    0.831.28
    Against its peers: 3 of 6Peers' median 0.75

Peers: US companies of the same industry (of its sector when the industry has too few) from a tenth to ten times its market value, the six closest in size. Updated weekly.

Colgate-Palmolive Company growth and profitability

Revenue (TTM)
21.28B USD
Net income (TTM)
2.05B USD
Gross margin
60.61%
Operating margin
20.38%
Net margin
9.65%

Revenue / Net income

Revenue Net income Net margin
PeriodRevenueGrowthNet incomeGrowthGross marginOperating marginNet marginEBITDAGrowth
FY202520.38B+1.40%2.13B-26.20%60.11%16.22%10.46%4.87B+0.31%
FY202420.10B+3.31%2.89B+25.61%60.23%21.80%14.37%4.85B+14.30%
FY202319.46B+8.29%2.30B+28.85%57.82%21.23%11.82%4.25B+25.92%
FY202217.97B+3.13%1.79B-17.59%56.49%19.95%9.93%3.37B-10.32%
FY202117.42B+5.77%2.17B-19.63%59.08%22.31%12.43%3.76B-13.48%

Colgate-Palmolive Company revenue breakdown

By product

FY2025
Oral, Personal and Home Care: 77.4%Pet Nutrition: 22.6%77.4%Oral, Personal and Home Care22.6%Pet Nutrition
SegmentRevenueShare of revenueChange on the year
Oral, Personal and Home Care15.77B77.4%+1.0%
Pet Nutrition4.61B22.6%+2.9%

By region

FY2025
Oral, Personal and Home Care: 60.9%Pet Nutrition: 39.1%60.9%Oral, Personal and Home Care39.1%Pet Nutrition
RegionRevenueShare of revenueChange on the year
Oral, Personal and Home Care4.78B60.9%—
Pet Nutrition3.06B39.1%—

How Colgate-Palmolive Company makes its money

Oral, Personal and Home Care15.77B 77.4%
Pet Nutrition4.61B 22.6%
Revenue20.38B 100.0%
Cost of revenue8.13B 39.9%
Gross profit12.25B 60.1%
Research and development366.00M 1.8%
Selling and administration7.89B 38.7%
Other operating expenses692.00M 3.4%
Operating income3.31B 16.2%
Tax798.00M 3.9%
Other expense376.00M 1.8%
Net income2.13B 10.5%

FY2025, in USD. Each band is as wide as its money; the percentage is its share of revenue.

Colgate-Palmolive Company dividends

Annual dividend
2.12 USD
Dividend yield (indicated)
2.15%
Payout ratio
81.97%
Years of dividend growth
53
Frequency
Quarterly
Last payment
0.53 USD
Last ex-dividend date
20 Oct 2026
Last payment date
13 Nov 2026

Dividends per share

Year2025202420232022202120202019201820172016
Dividends per share2.061.981.911.861.791.751.711.661.591.55

Colgate-Palmolive Company financial health

Cash and short-term investments
1.53B USD
Total debt
7.72B USD
Net cash
-6.19B USD
Free cash flow (TTM)
3.79B USD
Current ratio
0.96
Debt to equity
26.79
Piotroski score
9 / 9
Altman Z-score
7.04

Cash, debt and free cash flow

Cash and short-term investments Total debt Free cash flow
Fiscal yearCash and short-term investmentsTotal debtFree cash flow
FY20251.29B8.55B3.63B
FY20241.26B8.51B3.55B
FY2023966.00M9.06B3.04B
FY2022775.00M9.27B1.86B
FY2021832.00M7.83B2.76B

Colgate-Palmolive Company ownership

Institutions
84.24%
Institutional holders
2,080 (+59)
Free float
93.86%

Who owns the shares

Institutions 84.2% Others 15.8%
As of 30 Jun 2026

Shares free to trade

Free float 746.11M shares ·93.9% Closely held 48.81M shares ·6.1%

Closely held shares belong to insiders, founders and owners of more than 5%, and seldom change hands. The free float is the rest: the shares anyone can buy and sell.

Insider trading

QuarterPurchasesSalesShares acquiredShares disposed of
Q4 20260344.10K106.63K
Q3 202604642.58K686.39K
Q2 20260239.65K34.25K
Q1 202608483.05K614.44K

Shares outstanding

Basic shares Diluted shares Change in diluted shares
Fiscal yearBasic sharesDiluted sharesChange in diluted shares
FY2025808.70M811.10M-1.39%
FY2024817.70M822.50M-0.81%
FY2023827.40M829.20M-1.14%
FY2022836.40M838.80M-1.12%
FY2021845.00M848.30M-1.28%

Source: Financial Modeling Prep

Related Instruments

Title: Colgate/Palmolive Company

Sector: Consumer Defensive
Industry: Household & Personal Products
Since its founding in 1806, Colgate-Palmolive has grown into a leading player in the household and personal care industry. In addition to its namesake oral care line (which accounts for more than 40% of its total sales), the firm manufactures shampoos, shower gels, deodorants, and home care products sold in over 200 countries. International sales account for about 70% of its total business, including nearly half from emerging regions. It also owns the specialty pet food maker Hill's (which accounts for almost one-fourth of its sales), where the majority of its products are sold through veterinarians and specialty pet retailers.

Common questions about Colgate-Palmolive Company stock